Nicoletta Carlo-Stella

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: LinkedIn

Nicoletta Carlo-Stella, MD, PhD, (b. 1966) is a rheumatologist with the Internal Medicine Department at a hospital in Pavia, Italy.[1][2]

She is one of the authors of the 2011 case definition, International Consensus Criteria.[3]


Studies[edit | edit source]

  • 2004, Chronic fatigue syndrome: a review[4](Abstract)
  • 2006, A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles.[5]
  • 2009, Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome.[6]
  • 2009, Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.[7]
  • 2010, Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al.[8]
  • 2011, Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome.[9]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

References[edit | edit source]

  1. https://it.linkedin.com/in/nicoletta-carlo-stella-b0044323
  2. http://prabook.com/web/person-view.html?profileId=157252
  3. Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (Aug 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890Freely accessible. PMID 21777306. 
  4. Carlo-Stella, N; Lorusso, L; Candura, SM; Cuccia, M (2004), "Chronic fatigue syndrome: a review", Recenti Prog Med, 96 (11): 546-52, PMID 15598093 
  5. Carlo-Stella, N; Badulli, C; De Silvestri, A; Bazzichi, L; Martinetti, M; Lorusso, L; Bombardieri, S; Salvaneschi, L; Cuccia, M (2006), "A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles", Clinical and Experimental Rheumatology, 24 (2): 179-82, PMID 16762155 
  6. Carlo-Stella, N; Cuccia, M (2009), "Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome.", Reumatismo, 61 (4): 285-9, doi:10.4081/reumatismo.2009.285 
  7. Carlo-Stella, N; Bozzini, S; De Silvestri, A; Sbarsi, I; Pizzochero, C; Lorusso, L; Martinetti, M; Cuccia, M (2009), "Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome", International Journal of Immunopathology and Pharmacology, 22 (3): 745-54, doi:10.1177/039463200902200320, PMID 19822091 
  8. Carlo-Stella N. (2010) Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al. Brain, Behavior, and Immunity, 24 (7):1218; author reply 1219. doi: 10.1016/j.bbi.2010.06.004. Epub 2010 Jun 16.Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561580
  9. Pasi, A; Bozzini, S; Carlo-Stella, N; Martinetti, M; Bombardieri, S; De Silvestri, A; Salvaneschi, L; Cuccia, M (2011), "Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome", Molecular Medicine Reports, 4 (3): 535-40, doi:10.3892/mmr.2011.447 

Antibody - Antibodies or immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.